Ultra-RT Ultratrutide™

$75.00

Ultra-RT Ultratrutide™ is an advanced experimental quad-agonist peptide developed for metabolic pathway research, combining GLP-1, GIP, Glucagon, and Ghrelin receptor activity into a single innovative research compound designed to explore body composition, energy utilization, and lean tissue signaling pathways.

  • Advanced quad-agonist targeting four metabolic receptor pathways
  • Combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity
  • Designed for body composition and metabolic pathway research
  • Supports investigation of lean tissue signaling mechanisms
  • Innovative next-generation research peptide architecture
Description

Ultra-RT Ultratrutide™ – Advanced Quad-Agonist Peptide for Metabolic Pathway Research

Ultra-RT Ultratrutide™ is an advanced quad-agonist peptide built for metabolic pathway research. It combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity into one research compound. As a result, labs can study several metabolic and hormone pathways at the same time.

Because of this multi-pathway design, researchers can explore energy use, nutrient balance, metabolic control, and lean tissue signaling in one model.

In addition, Ultra-RT Ultratrutide™ goes beyond standard incretin-based compounds by adding Ghrelin receptor activity. Therefore, it gives researchers a broader way to study how the body balances energy use and tissue support during metabolic changes.

Mechanisms of Action

GLP-1 Receptor Activity
GLP-1 receptor activity supports research into satiety signals, glycemic balance, and metabolic control.

GIP Receptor Activity
Likewise, GIP receptor activity helps researchers study insulin signaling, nutrient use, and metabolic efficiency.

Glucagon Receptor Activity
In addition, Glucagon receptor activity allows for research into thermogenesis, liver energy output, and fat metabolism pathways.

Ghrelin Receptor Activity
Finally, Ghrelin receptor agonism targets GHS-R1a pathways and supports research into growth hormone signaling and lean tissue support.

Research Applications
Researchers often use this quad-agonist peptide in studies involving:

  • Multi-pathway metabolic optimization
  • Energy use and nutrient balance
  • Lean tissue signaling during caloric restriction
  • Body composition pathway analysis
  • Hormone response during metabolic shifts

Why Researchers Choose This Quad-Agonist Peptide

Most traditional metabolic research compounds focus only on appetite and glucose pathways. However, Ultra-RT Ultratrutide™ adds Ghrelin receptor activity for a broader research profile.

Because of this added pathway, researchers can study metabolic, anabolic, and recovery-related signaling in one compound.

Overall, Ultra-RT Ultratrutide™ offers labs a next-generation tool for advanced metabolic pathway research.

Research Use Notice

Ultra-RT Ultratrutide™ is intended strictly for laboratory research and analytical purposes only. It is not for human or veterinary use.

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.